These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 17173138)

  • 21. Immune response: the key to bone resorption in periodontal disease.
    Taubman MA; Valverde P; Han X; Kawai T
    J Periodontol; 2005 Nov; 76(11 Suppl):2033-41. PubMed ID: 16277573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone morphogenetic protein 2 stimulates osteoclast differentiation and survival supported by receptor activator of nuclear factor-kappaB ligand.
    Itoh K; Udagawa N; Katagiri T; Iemura S; Ueno N; Yasuda H; Higashio K; Quinn JM; Gillespie MT; Martin TJ; Suda T; Takahashi N
    Endocrinology; 2001 Aug; 142(8):3656-62. PubMed ID: 11459815
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vitamin D hormone inhibits osteoclastogenesis in vivo by decreasing the pool of osteoclast precursors in bone marrow.
    Shibata T; Shira-Ishi A; Sato T; Masaki T; Masuda A; Hishiya A; Ishikura N; Higashi S; Uchida Y; Saito MO; Ito M; Ogata E; Watanabe K; Ikeda K
    J Bone Miner Res; 2002 Apr; 17(4):622-9. PubMed ID: 11918219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T-cells mediate an inhibitory effect of interleukin-4 on osteoclastogenesis.
    Mirosavljevic D; Quinn JM; Elliott J; Horwood NJ; Martin TJ; Gillespie MT
    J Bone Miner Res; 2003 Jun; 18(6):984-93. PubMed ID: 12817750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IFN-gamma-producing human T cells directly induce osteoclastogenesis from human monocytes via the expression of RANKL.
    Kotake S; Nanke Y; Mogi M; Kawamoto M; Furuya T; Yago T; Kobashigawa T; Togari A; Kamatani N
    Eur J Immunol; 2005 Nov; 35(11):3353-63. PubMed ID: 16220542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inducible production of nitric oxide in osteoblast-like cells and in fetal mouse bone explants is associated with suppression of osteoclastic bone resorption.
    Löwik CW; Nibbering PH; van de Ruit M; Papapoulos SE
    J Clin Invest; 1994 Apr; 93(4):1465-72. PubMed ID: 8163651
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transforming growth factor beta affects osteoclast differentiation via direct and indirect actions.
    Quinn JM; Itoh K; Udagawa N; Hausler K; Yasuda H; Shima N; Mizuno A; Higashio K; Takahashi N; Suda T; Martin TJ; Gillespie MT
    J Bone Miner Res; 2001 Oct; 16(10):1787-94. PubMed ID: 11585342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostaglandin E2 induces expression of receptor activator of nuclear factor-kappa B ligand/osteoprotegrin ligand on pre-B cells: implications for accelerated osteoclastogenesis in estrogen deficiency.
    Kanematsu M; Sato T; Takai H; Watanabe K; Ikeda K; Yamada Y
    J Bone Miner Res; 2000 Jul; 15(7):1321-9. PubMed ID: 10893680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Attenuation of osteoclastogenesis and osteoclast function by apigenin.
    Bandyopadhyay S; Lion JM; Mentaverri R; Ricupero DA; Kamel S; Romero JR; Chattopadhyay N
    Biochem Pharmacol; 2006 Jul; 72(2):184-97. PubMed ID: 16750176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin-6 modulates production of T lymphocyte-derived cytokines in antigen-induced arthritis and drives inflammation-induced osteoclastogenesis.
    Wong PK; Quinn JM; Sims NA; van Nieuwenhuijze A; Campbell IK; Wicks IP
    Arthritis Rheum; 2006 Jan; 54(1):158-68. PubMed ID: 16385511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
    J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced osteoclast development in collagen-induced arthritis in interferon-gamma receptor knock-out mice as related to increased splenic CD11b+ myelopoiesis.
    De Klerck B; Carpentier I; Lories RJ; Habraken Y; Piette J; Carmeliet G; Beyaert R; Billiau A; Matthys P
    Arthritis Res Ther; 2004; 6(3):R220-31. PubMed ID: 15142268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.
    Valverde P; Tu Q; Chen J
    J Bone Miner Res; 2005 Sep; 20(9):1669-79. PubMed ID: 16059638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluorosis increases the risk of postmenopausal osteoporosis by stimulating interferon γ.
    Lv YG; Kang L; Wu G
    Biochem Biophys Res Commun; 2016 Oct; 479(2):372-379. PubMed ID: 27644876
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RANK ligand and interferon gamma differentially regulate cathepsin gene expression in pre-osteoclastic cells.
    Pang M; Martinez AF; Jacobs J; Balkan W; Troen BR
    Biochem Biophys Res Commun; 2005 Mar; 328(3):756-63. PubMed ID: 15694411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T cell activation induces human osteoclast formation via receptor activator of nuclear factor kappaB ligand-dependent and -independent mechanisms.
    Weitzmann MN; Cenci S; Rifas L; Haug J; Dipersio J; Pacifici R
    J Bone Miner Res; 2001 Feb; 16(2):328-37. PubMed ID: 11204433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CTRP3 acts as a negative regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling in vitro and RANKL-induced calvarial bone destruction in vivo.
    Kim JY; Min JY; Baek JM; Ahn SJ; Jun HY; Yoon KH; Choi MK; Lee MS; Oh J
    Bone; 2015 Oct; 79():242-51. PubMed ID: 26103094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Osteopenia in X-linked hyper-IgM syndrome reveals a regulatory role for CD40 ligand in osteoclastogenesis.
    Lopez-Granados E; Temmerman ST; Wu L; Reynolds JC; Follmann D; Liu S; Nelson DL; Rauch F; Jain A
    Proc Natl Acad Sci U S A; 2007 Mar; 104(12):5056-61. PubMed ID: 17360404
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interactions among human immunodeficiency virus (HIV)-1, interferon-gamma and receptor of activated NF-kappa B ligand (RANKL): implications for HIV pathogenesis.
    Fakruddin JM; Laurence J
    Clin Exp Immunol; 2004 Sep; 137(3):538-45. PubMed ID: 15320903
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of T cell-dependent and RANKL-dependent osteoclastogenic processes associated with high levels of bone mass in interleukin-15 receptor-deficient mice.
    Djaafar S; Pierroz DD; Chicheportiche R; Zheng XX; Ferrari SL; Ferrari-Lacraz S
    Arthritis Rheum; 2010 Nov; 62(11):3300-10. PubMed ID: 20617528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.